Literature DB >> 21989304

Infection: prostate biopsy-infection and prior fluoroquinolone exposure.

Michael A Liss1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21989304     DOI： 10.1038/nrurol.2011.153

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Best practice policy statement on urologic surgery antimicrobial prophylaxis.

Authors:  J Stuart Wolf; Carol J Bennett; Roger R Dmochowski; Brent K Hollenbeck; Margaret S Pearle; Anthony J Schaeffer
Journal:  J Urol       Date:  2008-02-20       Impact factor: 7.450

2.  Prevalence of antimicrobial resistance in intestinal flora of patients undergoing prostatic biopsy: implications for prophylaxis and treatment of infections after biopsy.

Authors:  Deepak Batura; G Gopal Rao; Peder Bo Nielsen
Journal:  BJU Int       Date:  2010-03-16       Impact factor: 5.588

3.  EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease.

Authors:  Axel Heidenreich; Joaquim Bellmunt; Michel Bolla; Steven Joniau; Malcolm Mason; Vsevolod Matveev; Nicolas Mottet; Hans-Peter Schmid; Theo van der Kwast; Thomas Wiegel; Filliberto Zattoni
Journal:  Eur Urol       Date:  2010-10-28       Impact factor: 20.096

4.  Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms.

Authors:  Bülent Akduman; Deniz Akduman; Hüsnü Tokgöz; Bülent Erol; Tuğrul Türker; Ferruh Ayoğlu; Necmettin Aydın Mungan
Journal:  Urology       Date:  2011-06-25       Impact factor: 2.649

5.  A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection.

Authors:  C K Naughton; D C Miller; D E Mager; D K Ornstein; W J Catalona
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

6.  Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.

Authors:  Michael A Liss; Alexandra Chang; Rosanne Santos; Amy Nakama-Peeples; Ellena M Peterson; Kathryn Osann; John Billimek; Richard J Szabo; Atreya Dash
Journal:  J Urol       Date:  2011-02-22       Impact factor: 7.450

7.  Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor.

Authors:  Ashraf A Mosharafa; Mohamed H Torky; Wael M El Said; Alaa Meshref
Journal:  Urology       Date:  2011-07-22       Impact factor: 2.649

8.  Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy.

Authors:  Robert K Nam; Refik Saskin; Yuna Lee; Ying Liu; Calvin Law; Laurence H Klotz; D Andrew Loblaw; John Trachtenberg; Aleksandra Stanimirovic; Andrew E Simor; Arun Seth; David R Urbach; Steven A Narod
Journal:  J Urol       Date:  2010-01-20       Impact factor: 7.450

9.  High prevalence of extended-spectrum beta-lactamase-producing enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: a need for changing preventive protocol.

Authors:  Juan P Horcajada; Marcos Busto; Santiago Grau; Luisa Sorlí; Roser Terradas; Margarita Salvadó; Jośe A Lorente; Araceli González; Hernando Knobel
Journal:  Urology       Date:  2009-10-07       Impact factor: 2.649

10.  Ultrasound guided transrectal core biopsies of the palpably abnormal prostate.

Authors:  K K Hodge; J E McNeal; T A Stamey
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450
  10 in total
  2 in total

1.  Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy.

Authors:  Michael A Liss; Ellena M Peterson; Brian Johnston; Kathryn Osann; James R Johnson
Journal:  Urology       Date:  2013-01-17       Impact factor: 2.649

2.  "Targeted" prophylaxis: Impact of rectal swab culture-directed prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy.

Authors:  Prabhjot Singh; Ashish Kumar; Siddharth Yadav; Lok Prakash; Brusabhanu Nayak; Rajeev Kumar; Arti Kapil; Prem Nath Dogra
Journal:  Investig Clin Urol       Date:  2017-08-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.